Business Wire

NATS Partners with Quintiq to Solve Complex Planning Puzzle of 1,500 Employees Handling More Than 7,000 Flights Daily

Jaa

NATS, the UK’s leading ANSP (air navigation service provider), has chosen Quintiq, a Dassault Systèmes brand, to overcome its rostering challenges in a highly complex planning environment. NATS manages air traffic over the UK as well as the eastern part of the Atlantic Ocean and provides ATC (air traffic control) services to 13 UK airports. With an operational workforce of 1,500 handling an average of 5,000 to 7,000 flights daily, NATS needs to ensure the allocation of the right people with the right skills at the right time. To achieve this NATS sought a solution to integrate rosters and resources to increase accuracy and make the planning process more efficient.

NATS Chief Information Officer Gavin Walker, describes the company’s current planning challenges, “Rosters follow detailed labour rules and regulations; we’re using different planning systems, many of them requiring manual input, so it’s a time-consuming process.”

“The new Quintiq planning system can support NATS’ business requirements, which includes adherence to the many layers of rostering rules found in our regulated industry. Our requirements are to perform the short-term planning up to nine months ahead as well as support the medium-term planning up to 24 months ahead. Meanwhile, the software allows fast re-planning, respecting those labour rules and regulations, should last-minute disruptions occur. The optimiser function releases planners from time-consuming work every time something changes, so that they can focus their expertise exactly where and when it’s needed.”

The Quintiq solution will be used to plan for air traffic controller officers (ATCOs), air traffic service assistants (ATSAs), and for support personnel. Employees also have non-operational duties such as project meetings and training that need to be incorporated into the rosters.

Gavin elaborates, “We chose Quintiq because they were able to accommodate our specific labour and safety regulations, training, holidays, simulation work and overtime management. The software can be configured to achieve this.”

In addition to the core roster functionality, NATS was also looking to take employee preferences into consideration with a system that can be accessed from home or via mobile. The Quintiq answer to this is a mobile application, which allows interactive communication between ATCOs or ATSAs and the planners when creating new requests or checking the status of existing requests. For employees, this means a single point of contact for all shift-related communications and tasks. Next to this, the Quintiq planning and optimisation software also provides a holistic view of resource demand and supply, reporting and scenario planning.

Rob van Egmond, CEO of Quintiq, is proud of NATS’ confidence in Quintiq, “With a highly specialised workforce in a highly regulated industry, NATS presented just the kind of complex puzzle we at Quintiq live to solve. We’ve recently made great inroads in the aviation sector where we serve some of the largest players: DFS, Fraport, Copenhagen Airports, Virgin Atlantic Airways and now NATS. We look forward to driving business efficiency across multiple planning horizons for NATS.”

About NATS

NATS is the UK's leading provider of air traffic control services. It operates out of Swanwick in Hampshire, England and Prestwick in Ayrshire, Scotland. Each year, it handles 2.3 million flights and 250 million passengers in the UK airspace. Besides providing services to 13 UK airports and managing all upper airspace in the UK, it also provides services across Europe, the Middle East, Asia and North America. Find out more at nats.aero.

About Quintiq

Every business has its supply chain planning puzzles. Some of those puzzles are large, some are complex and some seem impossible to solve. Since 1997, Quintiq has been solving each of those puzzles using a single supply chain planning and optimisation software. Today, approximately 12,000 users in over 80 countries rely on Quintiq software to plan and optimise workforces, logistics and production. Quintiq is part of Dassault Systèmes (Euronext Paris: #13065, DSY.PA) and has headquarters in the Netherlands and the USA, and offices around the world.

For more information, visit quintiq.com or follow Quintiq on Twitter, Facebook, LinkedIn and YouTube.

Contact information

Quintiq
North America Enquiries
Katie Kennedy
Gregory FCA
Tel: +1 610 228 2128
quintiq@gregoryfca.com
or
EMEA Enquiries
Richard Ratcliffe
Weber Shandwick
+44 207 067 0846
quintiq@webershandwick.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13Tiedote

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21Tiedote

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38Tiedote

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00Tiedote

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 12:00Tiedote

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme